US Patent 7951957 Substituted benzimidazoles and their use for inducing apoptosis
Patent 7951957 was granted and assigned to Basilea Pharmaceutica on May, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+64 characters)
Article
Patent abstract
The invention relates to compounds of formula (I)
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Alessandro Strebel0
Felix Bachmann0
Goutam Saha0
Martin Eberle0
Subho Roy0
Sudhir Srivastava0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07951957 Substituted benzimidazoles and their use for inducing apoptosis US Patent 7951957 Substituted benzimidazoles and their use for inducing apoptosis
Infobox
Patent Number
07951957
Patent Number
7951957
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07951957 Substituted benzimidazoles and their use for inducing apoptosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07951957
Date of patent
May 31, 2011
Patent application number
12173869
Date Filed
July 16, 2008
Patent primary examiner
Find more entities like US Patent 7951957 Substituted benzimidazoles and their use for inducing apoptosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
